CLINICAL TRIAL SURVIVAL ANALYSIS OVERVIEW
페이지 정보
작성일 22-12-29 17:07
본문
Download : CLINICAL TRIAL SURVIVAL ANALYSIS OVERVIEW.pptx
Download : CLINICAL TRIAL SURVIVAL ANALYSIS OVERVIEW.pptx( 26 )
_SLIDE_1_
CLINICAL TRIAL
SURVIVAL ANALYSIS
OVERVIEW
_SLIDE_2_
CLINICAL TRIAL
SURVIVAL ANALYSIS
OVERVIEW
_SLIDE_3_
CONTENTS
1. Clinical Trials
3. Phase 3
2. Phase 1
_SLIDE_4_
WHY CLINICAL TRIAL
Effectiveness of intervention to treat a disease
Safety of a new drug or device
Defining dose administration
Testing drug formulation
Exploring combination therapies
Evaluating effect of therapies on quality of life
_SLIDE_5_
BRIEF OF PHASES
Phase 1
Phase 2
Phase 3
Phase 4
No. of Participants
15-30
100-300
100 to thousands
Several hundreds to several thousands
Purpose
First in humans
safe dose
POC
1/3 fail
Determine efficacy
Safety
50% fail
Compare new agent with standard treatment
Safety
1/3 fail
Post market
Long-term safety and efficacy
_SLIDE_6_
PHASE 1
_SLIDE_7_
3 methods in Phase 1
Standard Method
Continual Reassessment Method(CRM)
Accelerated
Titration
Design(ATD)
Rule-based design
proceeds with
cohorts of t…(To be continued )
순서
CLINICAL,TRIAL,SURVIVAL,ANALYSIS,OVERVIEW,기타,레포트
CLINICAL TRIAL SURVIVAL ANALYSIS OVERVIEW , CLINICAL TRIAL SURVIVAL ANALYSIS OVERVIEW기타레포트 , CLINICAL TRIAL SURVIVAL ANALYSIS OVERVIEW






레포트/기타
CLINICAL TRIAL SURVIVAL ANALYSIS OVERVIEW
CLINICAL TRIAL SURVIVAL ANALYSIS OVERVIEW
설명
다.